Association analysis of GRIN2B, encoding N-methyl-D-aspartate receptor 2B subunit, and Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 25, Issue 3, 2008, Pages 287-292

  Seripa, Davide ^a,b   Matera, Maria Giovanna ^a   Franceschi, Marilisa ^a   Bizzarro, Alessandra ^c   Paris, Francesco ^a   Cascavilla, Leandro ^a   Rinaldi, Monica ^d   Panza, Francesco ^f   Solfrizzi, Vincenzo ^f   Daniele, Antonio ^c   Masullo, Carlo ^c   Dallapiccola, Bruno ^b,e   Pilotto, Alberto ^a  

^a Gerontology Geriatrics Research Laboratory   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d CNR   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF BARI   (Italy)

Author keywords

Alzheimer's disease; Glutamate receptor, ionotropic, N methyl D aspartate 2B; N methyl D aspartate; Single nucleotide polymorphism

Indexed keywords

APOLIPOPROTEIN E; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RECEPTORS, N-METHYL-D-ASPARTATE; SEVERITY OF ILLNESS INDEX;

EID: 40549140734     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118634     Document Type: Article

References (40)

1. Cummings JL: Alzheimer's disease. N Engl J Med 2004;351:56-67.
2. Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet 2006;368:387-403.
3. Wang H, Hu Y, Tsien JZ: Molecular and systems mechanisms of memory consolidation and storage. Prog Neurobiol 2006;79:123-135.
4. Langa KM, Foster NL, Larson EB: Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004;292:2901-2908.
5. Koch HJ, Szecsey A, Haen E: NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer's and vascular dementia. Curr Pharm Des 2004;10:253-259.
6. Doraiswamy PM: Alzheimer's disease and the glutamate NMDA receptor. Psychopharmacol Bull 2003;37:41-49.
7. Chohan MO, Iqbal K: From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease. J Alzheimers Dis 2006;10:81-87.
8. Dingledine R, Borges K, Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61.
9. Hardingham GE, Bading H: The Yin and Yang of NMDA receptor signalling. Trends Neurosci 2003;26:81-89.
10. Aamodt SM, Constantine-Paton M: The role of neural activity in synaptic development and its implications for adult brain function. Adv Neurol 1999;79:133-144.
11. Nicoll RA, Malenka RC: Expression mechanisms underlying NMDA receptor-dependent long-term potentiation. Ann NY Acad Sci 1999;868:515-525.
12. Perez-Otano I, Ehlers MD: Homeostatic plasticity and NMDA receptor trafficking. Trends Neurosci 2005;28:229-238.
13. Charton JP, Herkert M, Becker CM, Schröder H: Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon. Brain Res 1999;816:609-617.
14. Rosenblum K, Dudai Y, Richter-Levin G: Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc Natl Acad Sci USA 1996;93:10457-10460.
15. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ: Genetic enhancement of learning and memory in mice. Nature 1999;401:63-69.
16. Sze C, Bi H, Kleinschmidt-DeMasters BK, Filley CM, Martin LJ: N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci 2001;182:151-159.
17. Hynd MR, Scott HL, Dodd PR: Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004;45:583-595.
18. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634.
19. Chohan MO, Iqbal K: From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease. J Alzheimers Dis 2006;10:81-87.
20. Pallas M, Camins A: Molecular and biochemical features in Alzheimer's disease. Curr Pharm Des 2006;12:4389-4408.
21. Di Maria E, Gulli R, Begni S, De Luca A, Bigotti S, Pasini A, Bellone E, Pizzuti A, Dalla Piccola B, Novelli G, Ajmar F, Pennarelli M, Mandich P: Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia. Am J Med Genet 2004;128B:27-29.
22. Tsai SJ, Liu HC, Liu TY, Cheng CY, Hong CJ: Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease. J Neural Transm 2002;109:483-488.
23. Tsai SJ, Liu HC, Liu TY, Cheng CY, Hong CJ: Association analysis for the genetic variants of the NMDA receptor subunit 2b and Alzheimer's disease. Dement Geriatr Cogn Disord 2002;13:91-94.
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;11:939-944.
25. Seripa D, Forno GD, Matera MG, Gravina C, Margaglione M, Palermo MT, Wekstein DR, Antuono P, Davis DG, Daniele A, Masullo C, Bizzarro A, Gennarelli M, Fazio VM: Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohorts of Alzheimer patients. Neurobiol Aging 2003;24:933-939.
26. Seripa D, Matera MG, D'Andrea RP, Gravina C, Masullo C, Daniele A, Bizzarro A, Rinaldi M, Antuono P, Wekstein DR, Dal Forno G, Fazio VM: Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism. Neurology 2004;62:1631-1633.
27. Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C, Squitti R, Palermo MT, Davis DG, Antuono P, Wekstein DR, Dobrina A, Gennarelli M, Fazio VM: Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 2005;26:455-464.
28. Seripa D, Franceschi M, Matera MG, Panza F, Kehoe PG, Gravina C, Orsitto G, Solfrizzi V, Di Minno G, Dallapiccola B, Pilotto A: Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from southern Italy. J Gerontol A Biol Sci Med Sci 2006;61:918-923.
29. Orsitto G, Seripa D, Panza F, Franceschi M, Cascavilla L, Placentino G, Matera MG, Paris F, Capurso C, Solfrizzi V, Dallapiccola B, Pilotto A: Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. Dement Geriatr Cogn Disord 2007;23:327-333.
30. Seripa D, Signori E, Gravina C, Matera MG, Rinaldi M, Fazio VM: Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Pathol 2006;15:180-185.
31. Miyatake R, Furukawa A, Suwaki H: Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol Psychiatry 2002;7:1101-1106.
32. http://statpages.org/ (accessed November 22, 2007).
33. The R Project for Statistical Computing. http://www.r-project.org/
34. Gerdes LA, Klausen IB, Sihm I, Færgeman O: Apoliporpotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
35. Excoffier L, Laval G, Schneider S: Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 2005;1:47-50.
36. Kocsis I, Vasarhelyi B, Gyorffy A, Gyorffy B: Reanalysis of genotype distributions published in Neurology between 1999 and 2002. Neurology 2004;63:357-358.
37. Pallas M, Camins A: Molecular and biochemical features in Alzheimer's disease. Curr Pharm Des 2006;12:4389-4408.
38. Chohan MO, Iqbal K: From tau to toxicity: emerging roles of NMDA receptor in Alzheimer's disease. J Alzheimers Dis 2006;10:81-87.
39. Religa D, Winblad B: Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms. Acta Neurobiol Exp (Wars) 2003;63:393-396.
40. Selkoe DJ: Alzheimer disease: mechanistic understanding predicts novel therapy. Ann Intern Med 2004;140:627-638.